The Latest Non-Redemption Agreements: May 9, 2023
by Marlena Haddad on 2023-05-09 at 5:33pm

Latest Non-Redemption Agreements: LAMF Global Ventures I and PowerUp


LAMF Global Ventures Corp. I (LGVC) Adds Non-Redemption Agreement

On May 8, LAMF Global Ventures Corp. I (NASDAQ:LGVC) and the Sponsor entered into further non-redemption agreements with additional unaffiliated third-party investors pursuant to which the Additional Investors have, in connection with the Extension Meeting, agreed not to redeem, or to reverse and revoke any prior redemption election with respect to 1,588,000 Non-Redeemed Shares.

Pursuant to the Additional Non-Redemption Agreements, the Sponsor has agreed to transfer to the Investors a number of Class B ordinary shares equal to 21% of the number of Non-Redeemed Shares, or 333,480 Founder Shares, and for each Additional Monthly Extension, a number of Founder Shares equal to 3.5% of the number of Non-Redeemed Shares, or 55,580 Founder Shares for each Additional Monthly Extension, or up to an aggregate of 666,960 Founder Shares if the Initial Extension and all Additional Monthly Extensions are implemented.

In the aggregate, the Initial Investors and Additional Investors agreed not to redeem, or to reverse and revoke any prior redemption election with respect to 2,888,000 Non-Redeemed Shares.

READ

PowerUp Acquisition Corp. (PWUP) Adds Non-Redemption Agreement

As previously reported, on April 27, 2023, PowerUp Sponsor LLC, the sponsor of PowerUp Acquisition Corp. (NASDAQ:PWUP), and the company, entered into a Non-Redemption Agreement and Assignment of Economic Interest with an unaffiliated third party in exchange for such third party agreeing not to redeem an aggregate of 150,000 Class A ordinary shares of the company.

In exchange for the foregoing commitment not to redeem such shares, the Sponsor agreed to transfer to such investor an aggregate of 75,000 Class B ordinary shares of the Company held by the Sponsor immediately following consummation of an initial business combination if such investor continues to hold such Non-Redeemed Shares through the meeting.

The sponsor and the company have since entered into five additional Non-Redemption Agreements with additional unaffiliated third parties. In exchange for such third parties agreeing not to redeem an aggregate of 750,000 Non-Redeemed Shares, the Sponsor has agreed to transfer to such investors an aggregate of 375,000 Class B Ordinary Shares.

READ

 

The Latest Non-Redemption Agreements: May 9, 2023
Recent Posts
by Nicholas Alan Clayton on 2025-06-26 at 7:04pm

FIGX Acquisition Corp. (NASDAQ:FIGXU) announced the pricing of its $131 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FIGXU”, Friday, June 27, 2025. The new SPAC aims to seek out a financial services target with a particular focus on wealth and asset managers with the potential to...

by Nicholas Alan Clayton on 2025-06-26 at 4:52pm

Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...

by Nicholas Alan Clayton on 2025-06-26 at 8:24am

At the SPAC of Dawn As pressure on Fed Chairman Jerome Powell increases, the market is set to ingest a raft of new indicators today as well as hear from Cleveland Fed President Beth Hammack on the potential interest rate path. Today will also see June’s 8th SPAC IPO as Cantor Equity Partners III Inc....

by Nicholas Alan Clayton on 2025-06-25 at 6:30pm

Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 26, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...

by Nicholas Alan Clayton on 2025-06-25 at 12:44pm

Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved